Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers
Authors:
- Asal Jalal AbadiAAAsal Jalal Abadi
- Ali ZarrabiAli Zarrabi
- Mohammad Hossein GholamiMGMohammad Hossein Gholami
- Sepideh MirzaeiSMSepideh Mirzaei
- Farid HashemiFHFarid Hashemi
- Amirhossein ZabolianAZAmirhossein Zabolian
- Maliheh EntezariMEMaliheh Entezari
- Kiavash HushmandiKHKiavash Hushmandi
- Milad AshrafizadehMAMilad Ashrafizadeh
- Haroon KhanHaroon Khan
- Alan Prem KumarAlan Prem Kumar
Open Access
- 18 February 2021
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 11 (2) , 304
Abstract
MicroRNAs (miRNAs) are well-known regulators of biological mechanisms with a small size of 19–24 nucleotides and a single-stranded structure. miRNA dysregulation occurs in cancer progression. miRNAs can function as tumor-suppressing or tumor-promoting factors in cancer via regulating molecular pathways. Breast and lung cancers are two malignant thoracic tumors in which the abnormal expression of miRNAs plays a significant role in their development. Phosphatase and tensin homolog (PTEN) is a tumor-suppressor factor that is capable of suppressing the growth, viability, and metastasis of cancer cells via downregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling. PTEN downregulation occurs in lung and breast cancers to promote PI3K/Akt expression, leading to uncontrolled proliferation, metastasis, and their resistance to chemotherapy and radiotherapy. miRNAs as upstream mediators of PTEN can dually induce/inhibit PTEN signaling in affecting the malignant behavior of lung and breast cancer cells. Furthermore, long non-coding RNAs and circular RNAs can regulate the miRNA/PTEN axis in lung and breast cancer cells. It seems that anti-tumor compounds such as baicalein, propofol, and curcumin can induce PTEN upregulation by affecting miRNAs in suppressing breast and lung cancer progression. These topics are discussed in the current review with a focus on molecular pathways.Keywords
Funding Information
- Ministry of Education - Singapore (T2EP30120-0042)
This publication has 321 references indexed in Scilit:
- CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34aPLOS ONE, 2013
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTENPLOS ONE, 2012
- Ursolic Acid Inhibits the Initiation, Progression of Prostate Cancer and Prolongs the Survival of TRAMP Mice by Modulating Pro-Inflammatory PathwaysPLOS ONE, 2012
- miRBase: integrating microRNA annotation and deep-sequencing dataNucleic Acids Research, 2010
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenograftsJournal of Clinical Investigation, 2010
- Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast CancerClinical Cancer Research, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- Role of a Novel PH-Kinase Domain Interface in PKB/Akt Regulation: Structural Mechanism for Allosteric InhibitionPLOS Biology, 2009
- TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotypeBreast Cancer Research and Treatment, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007